| 1 |
中华医学会感染病学分会肝衰竭与人工肝学组，中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2024年版)[J]. 中华临床感染病杂志，2024, 17(5):321-339.
|
| 2 |
Zhu L, Wang Q, Guo M, et al. Mesenchymal stem cell-derived exosomes in various chronic liver diseases: Hype or hope？[J]. J Inflamm Res, 2024, 17:171-189.
|
| 3 |
Zhang L, Ma XJ, Fei YY, et al. Stem cell therapy in liver regeneration: Focus on mesenchymal stem cells and induced pluripotent stem cells[J]. Pharmacol Ther, 2022, 232:108004.
|
| 4 |
Qu Y, Wang Z, Dong L, et al. Natural small molecules synergize mesenchymal stem cells for injury repair in vital organs: a comprehensive review[J]. Stem Cell Res Ther, 2024, 15:243.
|
| 5 |
李佳静，荀运浩. 间充质干细胞及其外泌体在急性肝衰竭中免疫调节作用的研究进展[J]. 浙江医学，2023, 45(21):2338-2343.
|
| 6 |
冉凤英，陈龙，罗丹，等. 间充质干细胞外泌体的研究进展[J/OL]. 中华细胞与干细胞杂志：电子版，2020, 10(5):292-296.
|
| 7 |
Wang N, Ma F, Song H, et al. Mesenchymal stem cell-derived extracellular vesicles for regenerative applications and radiotherapy[J]. Cell Transplant, 2025, 34:09636897241311019.
|
| 8 |
Gao FQ, Zhu JQ, Feng XD. Innovative mesenchymal stem cell treatments for fatty liver disease[J]. World J Stem Cells, 2024, 16(9):846-853.
|
| 9 |
Shen J, Cao J, Chen M, et al. Recent advances in the role of exosomes in liver fibrosis[J]. J Gastroenterol Hepatol, 2023, 38(7):1083-1088.
|
| 10 |
Huang D, Shen H, Xie F, et al. Role of mesenchymal stem cell-derived exosomes in the regeneration of different tissues[J]. J Biol Eng, 2024, 18(1):36.
|
| 11 |
Zou X, Brigstock D. Extracellular vesicles from mesenchymal stem cells: potential as therapeutics in metabolic dysfunction-associated steatotic liver disease (MASLD)[J]. Biomedicines, 2024,12(12):2848.
|
| 12 |
Tang Y, Zhou Y, Li HJ. Advances in mesenchymal stem cell exosomes: a review[J]. Stem Cell Res Ther, 2021, 12:71.
|
| 13 |
Li L, Liu Y, Wang K, et al. Stem cell exosomes: new hope and future potential for relieving liver fibrosis[J]. Clin Mol Hepatol, 2025,31(2):333-349.
|
| 14 |
Guo N, Wang Y, Wen Z, et al. Promising nanotherapeutics of stem cell extracellular vesicles in liver regeneration[J]. Regen Ther, 2024, 26:1037-1047.
|
| 15 |
叶青松，彭友俭，骆瑜. 细胞外泌体的分离提取标准化及临床转化进展[J]. 口腔疾病防治，2022, 30(9):609-619.
|
| 16 |
黄德发，陈杰，杨通，等. 三种方法提取血清外泌体的比较研究[J]. 现代检验医学杂志，2021, 36(6):139-142.
|
| 17 |
Liu Q, Fan T, Zheng Y, et al. Immunogenic exosome-encapsulated black phosphorus nanoparticles as an effective anticancer photo-nanovaccine[J]. Nanoscale, 2020, 12(38):19939-19952.
|
| 18 |
Huang WC, Li YC, Chen PX, et al. Mesenchymal stem cell therapy as a game-changer in liver diseases: review of current clinical trials[J]. Stem Cell Res Ther, 2025, 16(1):3.
|
| 19 |
Hu C, Wang L. Advances in the treatment of liver injury based on mesenchymal stem cell-derived exosomes[J]. Stem Cell Res Ther, 2024, 15:474.
|
| 20 |
Didamoony MA, Soubh AA, Ahmed LA. Cutting-edge insights into liver fibrosis: advanced therapeutic strategies and future perspectives using engineered mesenchymal stem cell-derived exosomes[J]. Drug Deliv Transl Res, 2025. [Epub ahead of print]
|
| 21 |
Zhao W, Li K, Li L, et al. Mesenchymal stem cell-derived exosomes as drug delivery vehicles in disease therapy[J]. Int J Mol Sci, 2024, 25(14):7715.
|
| 22 |
Wu L, Zhang L, Huang M, et al. Mesenchymal stem cell-derived exosomes: emerging as a promising cell-free therapeutic strategy for autoimmune hepatitis[J]. Biomolecules, 2024, 14(11):1353.
|
| 23 |
白佳萌，刘光伟，谢露，等. 间充质干细胞及其外泌体在肝再生领域的应用[J]. 中国组织工程研究，2022, 26(19):3071-3077.
|
| 24 |
Yuan YG, Wang JL, Zhang YX, et al. Biogenesis, composition and potential therapeutic applications of mesenchymal stem cells derived exosomes in various diseases[J]. Int J Nanomedicine, 2023, 18: 3177-3210.
|
| 25 |
Deng C, Hu J, He L, et al. Daucosterol combined with umbilical cord mesenchymal stem cell-derived exosomes can alleviate liver damage in liver failure mice by regulating the IL-6/STAT3 signaling pathway[J]. Cancer Biol Ther, 24(1):2184150.
|
| 26 |
Song XJ, Zhang L, Li Q, et al. hUCB-MSC derived exosomal miR-124 promotes rat liver regeneration after partial hepatectomy via downregulating Foxg1[J]. Life Sci, 2021, 265:118821.
|
| 27 |
胡明智，杨国安，孙晓林. 外泌体调控细胞自噬相关信号通路的研究进展[J]. 天津医药，2020, 48(10):1015-1020.
|
| 28 |
Zhang Y, Li Y, Wang Q, et al. Attenuation of hepatic ischemia-reperfusion injury by adipose stem cell-derived exosome treatment via ERK1/2 and GSK-3β signaling pathways[J]. Int J Mol Med, 2021, 49(2):13.
|
| 29 |
Xing H, Tan J, Miao Y, et al. Crosstalk between exosomes and autophagy: a review of molecular mechanisms and therapies[J]. J Cell Mol Med, 2021, 25(5):2297-2308.
|
| 30 |
Yang B, Duan W, Wei L, et al. Bone marrow mesenchymal stem cell-derived hepatocyte-like cell exosomes reduce hepatic ischemia/reperfusion injury by enhancing autophagy[J]. Stem Cells Dev, 2020, 29(6):372-379.
|
| 31 |
Zhang L, Song Y, Chen L, et al. MiR-20a-containing exosomes from umbilical cord mesenchymal stem cells alleviates liver ischemia/reperfusion injury[J]. J Cell Physiol, 2020, 235:3698-3710.
|
| 32 |
Zhao S, Liu Y, Pu Z. Bone marrow mesenchymal stem cell-derived exosomes attenuate D-GaIN/LPS-induced hepatocyte apoptosis by activating autophagy in vitro[J]. Drug Des Devel Ther, 2019, 13:2887.
|
| 33 |
Qu Y, Zhang Q, Cai X, et al. Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation[J]. J Cell Mol Med, 2017, 21(10):2491-2502.
|
| 34 |
高俪原，梁宝瑜，金春，等. 血管新生在肝脏疾病发生与发展中作用的研究进展[J]. 生理科学进展，2020, 51(3):193-197.
|
| 35 |
De Rudder M, Manco R, Coubeau L, et al. Vascular damage and excessive proliferation compromise liver function after extended hepatectomy in mice[J]. Hepatology, 2025, 81(5):1468-1484.
|
| 36 |
Kim ES, Kim SY, Moon A. C-reactive protein signaling pathways in tumor progression[J]. Biomol Ther (Seoul), 2023, 31(5):473-483.
|
| 37 |
Jun JH, Kim JY, Choi JH, et al. Exosomes from placenta-derived mesenchymal stem cells are involved in liver regeneration in hepatic failure induced by bile duct ligation[J]. Stem Cells Int, 2020:5485738.
|
| 38 |
Wang Y, Piao C, Liu T, et al. Exosomes derived from adipose mesenchymal stem cells promote regeneration of injured liver in minipigs[J]. Int J Mol Sci, 2024, 25(12):6604.
|
| 39 |
Fan B, Xie H, Tan Q, et al. Role of exosomal modulation of macrophages in liver fibrosis[J]. J Clin Transl Hepatol, 2024, 12(2):201-209.
|
| 40 |
Liu P, Qian Y, Liu X, et al. Immunomodulatory role of mesenchymal stem cell therapy in liver fibrosis[J]. Front Immunol, 2023, 13:1096402.
|
| 41 |
Rong X, Liu J, Yao X, et al. Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/β-catenin pathway[J]. Stem Cell Res Ther, 2019, 10: 98.
|
| 42 |
Ohara M, Ohnishi S, Hosono H, et al. Extracellular vesicles from amnion-derived mesenchymal stem cells ameliorate hepatic inflammation and fibrosis in rats[J]. Stem Cells Int, 2018:3212643.
|
| 43 |
Haga H, Yan IK, Borelli D, et al. Extracellular vesicles from bone marrow derived mesenchymal stem cells protect against murine hepatic ischemia-reperfusion injury[J]. Liver Transpl, 2017, 23(6):791-803.
|
| 44 |
Shao M, Xu Q, Wu Z, et al. Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate IL-6-induced acute liver injury through miR-455-3p[J]. Stem Cell Res Ther, 2020,11(1):37.
|
| 45 |
Zhang S, Jiang L, Hu H, et al. Pretreatment of exosomes derived from hUCMSCs with TNF-α ameliorates acute liver failure by inhibiting the activation of NLRP3 in macrophage[J]. Life Sci, 2020, 246:117401.
|
| 46 |
Khosrojerdi A, Soudi S, Hosseini AZ, et al. The combination of mesenchymal stem cell- and hepatocyte-derived exosomes, along with imipenem, ameliorates inflammatory responses and liver damage in a sepsis mouse model[J]. Life Sci, 2023, 326:121813.
|
| 47 |
Yan Y, Jiang W, Tan Y, et al. hucMSC exosome-derived GPX1 is required for the recovery of hepatic oxidant injury[J]. Mol Ther, 2017, 25(2):465-479.
|
| 48 |
Tan CY, Lai RC, Wong W, et al. Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models[J]. Stem Cell Res Ther, 2014, 5(3):76.
|
| 49 |
Chen L, Xiang B, Wang X, et al. Exosomes derived from human menstrual blood-derived stem cells alleviate fulminant hepatic failure[J]. Stem Cell Res Ther, 2017, 8(1):9.
|
| 50 |
Wu HY, Zhang XC, Jia BB, et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate acetaminophen-induced acute liver failure through activating ERK and IGF-1R/PI3K/AKT signaling pathway[J]. J Pharmacol Sci, 2021, 147(1): 143-155.
|
| 51 |
Jiang W, Tan Y, Cai M, et al. Human umbilical cord MSC-derived exosomes suppress the development of CCl4-induced liver injury through antioxidant effect[J]. Stem Cells Int, 2018, 2018(1):6079642.
|
| 52 |
Yao J, Zheng J, Cai J, et al. Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate rat hepatic ischemia-reperfusion injury by suppressing oxidative stress and neutrophil inflammatory response[J]. FASEB J, 2019, 33(2):1695-1710.
|
| 53 |
Cai J, Tang D, Hao X, et al. Mesenchymal stem cell-derived exosome alleviates sepsis- associated acute liver injury by suppressing MALAT1 through microRNA-26a-5p: an innovative immunopharmacological intervention and therapeutic approach for sepsis[J]. Front Immunol, 2023, 14:1157793.
|
| 54 |
Hazrati A, Malekpour K, Soudi S, et al. Mesenchymal stromal/stem cells and their extracellular vesicles application in acute and chronic inflammatory liver diseases: Emphasizing on the anti-fibrotic and immunomodulatory mechanisms[J]. Front Immunol, 2022, 13:865888.
|
| 55 |
Lu X, Hu H, Zhou Y, et al. One-step engineered mesenchymal stem cell-derived exosomes against hepatic ischemia-reperfusion injury[J]. Int J Pharm, 2025, 672:125292.
|
| 56 |
Chen L, Brenner DA, Kisseleva T. Combatting fibrosis: exosome‐based therapies in the regression of liver fibrosis[J]. Hepatol Commun, 2019, 3(2):180-192.
|